Neoadjuvant T-VEC in High Risk Early Melanoma
NCT04427306
·
clinicaltrials.gov ↗
PHASE2
Phase
SUSPENDED
Status
6
Enrollment
OTHER
Sponsor class
Stopped
low enrollment
Conditions
Melanoma
Interventions
DRUG:
T-Vec
Sponsor
University of California, Davis
Collaborators
[object Object]